Anti-CEACAM6 / CD66c Reference Antibody (NEO-201)
- Product Code: 139928
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in targeted cancer therapy, particularly for solid tumors expressing CEACAM6 such as colorectal, pancreatic, and lung cancers. Binds selectively to CEACAM6, enabling tumor detection and delivery of cytotoxic agents. Investigated for use in immunoimaging and antibody-drug conjugates (ADCs) to improve treatment specificity. Also supports cancer cell depletion in combination with immune effector mechanisms like ADCC and CDC. Currently in preclinical and early clinical development for oncology applications.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-CEACAM6 / CD66c Reference Antibody (NEO-201)
Used in targeted cancer therapy, particularly for solid tumors expressing CEACAM6 such as colorectal, pancreatic, and lung cancers. Binds selectively to CEACAM6, enabling tumor detection and delivery of cytotoxic agents. Investigated for use in immunoimaging and antibody-drug conjugates (ADCs) to improve treatment specificity. Also supports cancer cell depletion in combination with immune effector mechanisms like ADCC and CDC. Currently in preclinical and early clinical development for oncology applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :